Patents by Inventor Stephen Perrett

Stephen Perrett has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • STIMULATION OF THE GROWTH OF GUT BIFIDOBACTERIA
    Publication number: 20240082321
    Abstract: The present disclosure provides compositions for stimulating the growth of gut bifidobacteria, thereby maintaining/improving gut health. Of particular interest are compositions comprising cells of Lactobacillus fermentum, including the product LACTEOL®. Examples of specific conditions that may be treated which the compositions include antibiotic-associated diarrhea, dysbiosis, irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD).
    Type: Application
    Filed: April 30, 2021
    Publication date: March 14, 2024
    Inventors: Alicja WARDA, Colin HILL, Stephen PERRETT
  • ORALLY ADMINISTERED CORTICOSTEROID COMPOSITIONS
    Publication number: 20220339098
    Abstract: The present invention is directed to orally administered corticosteroid compositions. The present invention also provides a method for treating a condition associated with inflammation of the gastrointestinal tract in an individual. The method comprises administering to an individual in need thereof a pharmaceutical composition of the present invention.
    Type: Application
    Filed: January 5, 2022
    Publication date: October 27, 2022
    Inventors: Stephen PERRETT, Fredric Jay COHEN, Gopi M. VENKATESH
  • Cysteamine prodrugs
    Patent number: 11357750
    Abstract: Described herein are prodrugs of cysteamine and pharmaceutically acceptable salts, solvates, and esters thereof. Also described herein are pharmaceutical compositions comprising prodrugs of cysteamine, or pharmaceutically acceptable salts, solvates, and esters thereof, and methods of treatment comprising administering prodrugs of cysteamine, or pharmaceutically acceptable salts, solvates, and esters thereof.
    Type: Grant
    Filed: January 25, 2018
    Date of Patent: June 14, 2022
    Assignee: Children's Hospital Medical Center
    Inventor: Stephen Perrett
  • Orally administered corticosteroid compositions
    Patent number: 11266598
    Abstract: The present invention is directed to orally administered corticosteroid compositions. The present invention also provides a method for treating a condition associated with inflammation of the gastrointestinal tract in an individual. The method comprises administering to an individual in need thereof a pharmaceutical composition of the present invention.
    Type: Grant
    Filed: April 21, 2021
    Date of Patent: March 8, 2022
    Assignee: ELLODI PHARMACEUTICALS, L.P.
    Inventors: Stephen Perrett, Fredric Jay Cohen, Gopi M. Venkatesh
  • Orally administered corticosteroid compositions
    Patent number: 11246828
    Abstract: The present invention is directed to orally administered corticosteroid compositions. The present invention also provides a method for treating a condition associated with inflammation of the gastrointestinal tract in an individual. The method comprises administering to an individual in need thereof a pharmaceutical composition of the present invention.
    Type: Grant
    Filed: March 17, 2020
    Date of Patent: February 15, 2022
    Assignee: ELLODI PHARMACEUTICALS, L.P.
    Inventors: Stephen Perrett, Fredric Jay Cohen, Gopi M. Venkatesh
  • ORALLY ADMINISTERED CORTICOSTEROID COMPOSITIONS
    Publication number: 20210244660
    Abstract: The present invention is directed to orally administered corticosteroid compositions. The present invention also provides a method for treating a condition associated with inflammation of the gastrointestinal tract in an individual. The method comprises administering to an individual in need thereof a pharmaceutical composition of the present invention.
    Type: Application
    Filed: April 21, 2021
    Publication date: August 12, 2021
    Inventors: Stephen PERRETT, Fredric Jay Cohen, Gopi M. Venkatesh
  • NEW USE OF MICROBIOLOGICAL COMPOSITIONS
    Publication number: 20200405787
    Abstract: The present invention provides a pharmaceutical composition comprising dead cells of Lactobacillus strains useful for the protection of subjects against the development of conditions with behavioral, psychological and/or physical components caused or exacerbated by stress or anxiety, and/or useful in treating existing conditions with behavioral, psychological and/or physical components caused or exacerbated by stress or anxiety. Examples of specific conditions include stress, anxiety, depression, mood disturbances, sociability disorders, irritable bowel syndrome, autism, autism spectrum disorder, post-traumatic stress disorder, chronic stress and a range of other stress-related diseases.
    Type: Application
    Filed: March 22, 2019
    Publication date: December 31, 2020
    Inventors: Colin HILL, Ted DINAN, Alicja WARDA, Stephen PERRETT
  • HIGH POTENCY PANCREATIN PHARMACEUTICAL COMPOSITIONS
    Publication number: 20200255817
    Abstract: Provided herein are two-step, multi-step and double precipitation processes used to prepare HA-pancreatin having a specific lipase activity of at least 120 USP IU/mg. The present two-step processes include suspending pancreatin in an aqueous solvent and adding an organic solvent with a Hildebrand solubility parameter between about 38 and 45 (MPa)0.5 to precipitate HA-pancreatin. The present multi-step processes produce HA-pancreatin using additional solvents. Double precipitation processes are directed to the use of solvents having different Hildebrand solubility parameters to produce HA-pancreatin product for use as a therapeutic agent.
    Type: Application
    Filed: September 3, 2019
    Publication date: August 13, 2020
    Applicant: Allergan Pharmaceuticals International Limited
    Inventors: Stephen PERRETT, Robert BECKER, Luigi BOLTRI, Luigi GHIDORSI, Paola ARZUFFI, Vincenza PIRONTI
  • ORALLY ADMINISTERED CORTICOSTEROID COMPOSITIONS
    Publication number: 20200214979
    Abstract: The present invention is directed to orally administered corticosteroid compositions. The present invention also provides a method for treating a condition associated with inflammation of the gastrointestinal tract in an individual. The method comprises administering to an individual in need thereof a pharmaceutical composition of the present invention.
    Type: Application
    Filed: March 17, 2020
    Publication date: July 9, 2020
    Inventors: Stephen PERRETT, Fredric Jay Cohen, Gopi M. Venkatesh
  • Orally administered corticosteroid compositions
    Patent number: 10632069
    Abstract: The present invention is directed to orally administered corticosteroid compositions. The present invention also provides a method for treating a condition associated with inflammation of the gastrointestinal tract in an individual. The method comprises administering to an individual in need thereof a pharmaceutical composition of the present invention.
    Type: Grant
    Filed: November 17, 2017
    Date of Patent: April 28, 2020
    Assignee: Adare Pharmaceuticals US, L.P.
    Inventors: Stephen Perrett, Fredric Jay Cohen, Gopi Venkatesh
  • CYSTEAMINE PRODRUGS
    Publication number: 20200000762
    Abstract: Described herein are prodrugs of cysteamine and pharmaceutically acceptable salts, solvates, and esters thereof. Also described herein are pharmaceutical compositions comprising prodrugs of cysteamine, or pharmaceutically acceptable salts, solvates, and esters thereof, and methods of treatment comprising administering prodrugs of cysteamine, or pharmaceutically acceptable salts, solvates, and esters thereof.
    Type: Application
    Filed: January 25, 2018
    Publication date: January 2, 2020
    Applicant: Adare Pharmaceuticals, Inc.
    Inventor: Stephen PERRETT
  • ORALLY ADMINISTERED CORTICOSTEROID COMPOSITIONS
    Publication number: 20180153802
    Abstract: The present invention is directed to orally administered corticosteroid compositions. The present invention also provides a method for treating a condition associated with inflammation of the gastrointestinal tract in an individual. The method comprises administering to an individual in need thereof a pharmaceutical composition of the present invention.
    Type: Application
    Filed: November 17, 2017
    Publication date: June 7, 2018
    Inventors: Stephen Perrett, Fredric Jay Cohen, Gopi Venkatesh
  • Orally administered corticosteroid compositions
    Patent number: 9849084
    Abstract: The present invention is directed to orally administered corticosteroid compositions. The present invention also provides a method for treating a condition associated with inflammation of the gastrointestinal tract in an individual. The method comprises administering to an individual in need thereof a pharmaceutical composition of the present invention.
    Type: Grant
    Filed: July 8, 2016
    Date of Patent: December 26, 2017
    Assignee: ADARE PHARMACEUTICALS, INC.
    Inventors: Stephen Perrett, Fredric Jay Cohen, Gopi Venkatesh
  • ORALLY ADMINISTERED CORTICOSTEROID COMPOSITIONS
    Publication number: 20170071855
    Abstract: The present invention is directed to orally administered corticosteroid compositions. The present invention also provides a method for treating a condition associated with inflammation of the gastrointestinal tract in an individual. The method comprises administering to an individual in need thereof a pharmaceutical composition of the present invention.
    Type: Application
    Filed: July 8, 2016
    Publication date: March 16, 2017
    Inventors: Stephen PERRETT, Fredric Jay COHEN, Gopi VENKATESH
  • Orally administered corticosteroid compositions
    Patent number: 9486407
    Abstract: The present invention is directed to orally administered corticosteroid compositions. The present invention also provides a method for treating a condition associated with inflammation of the gastrointestinal tract in an individual. The method comprises administering to an individual in need thereof a pharmaceutical composition of the present invention.
    Type: Grant
    Filed: June 3, 2014
    Date of Patent: November 8, 2016
    Assignee: ADARE PHARMACEUTICALS, INC.
    Inventors: Stephen Perrett, Fredric Jay Cohen, Gopi Venkatesh
  • Orally administered corticosteroid compositions
    Patent number: 9387167
    Abstract: The present invention is directed to orally administered corticosteroid compositions. The present invention also provides a method for treating a condition associated with inflammation of the gastrointestinal tract in an individual. The method comprises administering to an individual in need thereof a pharmaceutical composition of the present invention.
    Type: Grant
    Filed: June 23, 2014
    Date of Patent: July 12, 2016
    Assignee: ADARE PHARMACEUTICALS, INC.
    Inventors: Stephen Perrett, Fredric Jay Cohen, Gopi Venkatesh
  • HIGH POTENCY PANCREATIN PHARMACEUTICAL COMPOSITIONS
    Publication number: 20160108389
    Abstract: The present disclosure provides high potency pharmaceutical compositions comprising high activity pancreatin enzymes. The invention is also directed to a process of producing HA-pancreatin enzymes and its compositions or dosage forms, and methods for their use.
    Type: Application
    Filed: December 14, 2015
    Publication date: April 21, 2016
    Inventors: Stephen PERRETT, Robert BECKER, Luigi BOLTRI, Luigi GHIDORSI, Paula ARZUFFI, Vincenza PIRONTI, Michael TOTA, William WARD
  • PANCREATIC ENZYME COMPOSITIONS AND METHODS FOR TREATING PANCREATITIS AND PANCREATIC INSUFFICIENCY
    Publication number: 20160051472
    Abstract: Compositions of the present invention, comprising the combination of enterically coated and uncoated pancreatic enzyme-containing beads are useful for treating or preventing pancreatitis pain, and optionally disorders associated with digestive enzyme deficiencies.
    Type: Application
    Filed: June 5, 2014
    Publication date: February 25, 2016
    Inventors: Stephen Perrett, Ruth Thieroff-Ekerdt, Gopi Venkatesh, Konstantinos Efthymiopoulos
  • ORALLY ADMINISTERED CORTICOSTEROID COMPOSITIONS
    Publication number: 20140303131
    Abstract: The present invention is directed to orally administered corticosteroid compositions. The present invention also provides a method for treating a condition associated with inflammation of the gastrointestinal tract in an individual. The method comprises administering to an individual in need thereof a pharmaceutical composition of the present invention.
    Type: Application
    Filed: June 23, 2014
    Publication date: October 9, 2014
    Inventors: Stephen PERRETT, Fredric Jay COHEN, Gopi VENKATESH
  • ORALLY ADMINISTERED CORTICOSTEROID COMPOSITIONS
    Publication number: 20140287051
    Abstract: The present invention is directed to orally administered corticosteroid compositions. The present invention also provides a method for treating a condition associated with inflammation of the gastrointestinal tract in an individual. The method comprises administering to an individual in need thereof a pharmaceutical composition of the present invention.
    Type: Application
    Filed: June 3, 2014
    Publication date: September 25, 2014
    Applicant: APTALIS PHARMATECH, INC.
    Inventors: Stephen PERRETT, Fredric Jay COHEN, Gopi VENKATESH